Market Data
News
Tools
Markets
Discover
Subscribe Login/Register
S&P ASX 200
7,098.30
(
-0.28%
)
S&P ASX All Technology
2,331.80
(
-2.38%
)
Brent Oil
76.97
(
0.24%
)
US Dollar vs AUD
1.50024
(
-0.09%
)
Bitcoin
26,409.49
(
0.22%
)
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AMAG Pharmaceuticals Inc (AMAG)

  7. AMAG Pharmaceuticals Inc (AMAG) Financials

AMAG

AMAG Pharmaceuticals Inc

13.75
0.00 (0.0%)
Upgrade to Real-Time

AMAG Pharmaceuticals Inc. (AMAG) Fundamentals
AMAG Pharmaceuticals Inc primarily uses its nanoparticle technology to develop therapeutic compounds to treat anemia in patients suffering from chronic kidney disease, as well as imaging agents that assist in identifying cancerous tumors. The company recently received Food and Drug Administration approval for Feraheme, a novel iron replacement drug for CKD patients suffering from anemia, and also offers GastroMARK, an imaging aid used with magnetic resonance imaging. Most of the revenues are generated through the sale of Feraheme and Makena which is a hydroxyprogesterone caproate injection.
SHARE INFORMATION
Market CapUS$ 477,469,616
Shares Outstanding34,725,063
Float16,763,509
Percent Float48.27%
Short Interest6,290,094.00
Short Percent Float18.2%
Short Interest Ratio1.83
Short Interest Date2020-10-30
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 327,752,000
Latest Fiscal EPSUS$ -13.69
Latest Fiscal Date2019-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions327
Institutional Holdings Date2020-10-31
Institutional Bought Previous 3 Months1,255,254
Institutional Holdings Percent44.4%
Institutional Sold Previous 3 Months5,895,367
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned2,152,314
TRADING INFO
52 Week HighUS$ 0.00
52 Week LowUS$ 0.00
52 Week High ChangeUS$ 0.00
21 Day Moving AverageUS$ 0.00
21 Day Extended Moving AverageUS$ 13.75
50 Day Moving AverageUS$ 0.00
50 Day Extended Moving AverageUS$ 13.75
200 Day Moving AverageUS$ 0.00
200 Day Extended Moving AverageUS$ 13.6462
10 Day Average Volume-
20 Day Average Volume-
30 Day Average Volume-
50 Day Average Volume-
Alpha0.008157
Beta0.8532
Standard Deviation0.186991
R20.062639
7 Day Price ChangeUS$ 0.00
7 Day Percent Change0.0%
21 Day Price ChangeUS$ 0.00
21 Day Percent Change0.0%
30 Day Price ChangeUS$ 0.00
30 Day Percent Change0.0%
Month to Date Price ChangeUS$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price ChangeUS$ 0.00
Quarter to Date Percent Change0.0%
180 Day Price ChangeUS$ 0.00
180 Day Percent Change0.0%
200 Day Price ChangeUS$ 0.00
200 Day Percent Change0.0%
Year to Date Price ChangeUS$ 0.00
Year to Date Percent Change0.0%

AMAG Pharmaceuticals Inc. (AMAG) Key Ratios

PROFITABILITY
EBIT Margin-68.2%
EBITDA Margin-56.3%
Pre-Tax Profit Margin-44.0%
Profit Margin Count-75.13%
Gross Margin89.6%
Profit Margin TOT-75.16%
INCOME STATEMENTS
RevenueUS$ 304,230,000
Revenue Per ShareUS$ 8.7611
Revenue (3 Years)US$ -20.57
Revenue (5 Years)US$ -6.36
FINANCIAL STRENGTH
Price to Tangible Book-2.80
Total Debt To Equity1.20
Int Coverage-8.20
Current Ratio1.70
Leverage Ratio2.90
Quick Ratio1.50
Long Term Debt To Capital0.55
VALUATION MEASURES
PE Ratio-2.10
Enterprise ValueUS$ 619,789,616
Price to Sales1.5694
Price to Free Cash-16.80
PE High Last 5 Years46.60
Price To Book1.90
Price To Cash Flow6.30
PE Low Last 5 Years-108.40
Price to Tangible Book-2.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.00
Invoice Turnover3.70
Assets Turnover0.30
Return Assets-25.97
Return on Equity-59.61
Return on Capital-31.16

AMAG Pharmaceuticals Inc. (AMAG) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOScott Myers
Employees440
Last AuditUE
CIK0000792977
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1100 Winter Street
Waltham, MA 2451
Websitehttps://www.amagpharma.com
Facsimile+1 617 649-1654
Telephone+1 617 498-3300
Emailllennox@amagpharma.com
Your Recent History
NASDAQ
AMAG
AMAG Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230608 05:42:40